QUANTUMPH-P 02228Prospectus Information

Prospectus Information
IPO Timeline
Broker Results (T-2)
2024-06-11
Some brokers release in afternoon
Grey Market (T-1)
2024-06-12
Afternoon
HKEX Allotment (T-1)
2024-06-12
Evening
Registrar Allotment (T-1)
2024-06-12
Evening
Listing Day (T)
2024-06-13
First day of trading
Company Overview
Stock NameQUANTUMPH-P
Stock Code02228
Company Full NameQUANTUMPH-P
Industry軟件服務
Principal Activities公司是一個世界前沿的基于量子物理、以人工智能賦能和機器人驅動的創新型研發平臺。
Listing Date2024-06-13
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國廣東省深圳市福田區紅柳道2號國際生物醫藥產業園二期三層
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttps://www.xtalpi.com/
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo data
Offering Information
Offering Mechanism To be extracted
Offer PriceHK$ 5.28 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)To be confirmed
Stabilizing Manager (Greenshoe)
Cornerstone Share34.1%
Clawback TiersTo be extracted
Reallocation OptionTo be confirmed
Total Global Offering SizeHK$ 197,868,000
Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 1,000 HK$ 5,280
2 lots 2,000 HK$ 10,560
3 lots 3,000 HK$ 15,840
4 lots 4,000 HK$ 21,120
5 lots 5,000 HK$ 26,400
6 lots 6,000 HK$ 31,680
7 lots 7,000 HK$ 36,960
8 lots 8,000 HK$ 42,240
9 lots 9,000 HK$ 47,520
10 lots 10,000 HK$ 52,800
15 lots 15,000 HK$ 79,200
20 lots 20,000 HK$ 105,600
25 lots 25,000 HK$ 132,000
30 lots 30,000 HK$ 158,400
35 lots 35,000 HK$ 184,800
40 lots 40,000 HK$ 211,200
45 lots 45,000 HK$ 237,600
50 lots 50,000 HK$ 264,000
60 lots 60,000 HK$ 316,800
70 lots 70,000 HK$ 369,600
80 lots 80,000 HK$ 422,400
90 lots 90,000 HK$ 475,200
100 lots 100,000 HK$ 528,000
200 lots 200,000 HK$ 1,056,000
300 lots 300,000 HK$ 1,584,000
400 lots 400,000 HK$ 2,112,000
500 lots 500,000 HK$ 2,640,000
600 lots 600,000 HK$ 3,168,000
700 lots 700,000 HK$ 3,696,000
800 lots 800,000 HK$ 4,224,000
900 lots 900,000 HK$ 4,752,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1,000 lots 1,000,000 HK$ 5,280,000
1,500 lots 1,500,000 HK$ 7,920,000
2,000 lots 2,000,000 HK$ 10,560,000
2,500 lots 2,500,000 HK$ 13,200,000
3,000 lots 3,000,000 HK$ 15,840,000
3,500 lots 3,500,000 HK$ 18,480,000
4,000 lots 4,000,000 HK$ 21,120,000
4,684 lots 4,684,000 HK$ 24,731,520
Valuation & Financials
Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)To be extracted
P/E RatioTo be extracted
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day Performance
First Day CloseHK$ 2.36
First Day OpenHK$ 2.44
First Day Change-0.84%
First Day Volume57379000.0
First Day Turnover138989000.0
Use of Proceeds
Use of Proceeds1、約75.0%或705.8百萬港元將用于持續提升研發能力及解決方案提供能力; 2、約15.0%或141.2百萬港元將用于提升在國內外的商業化能力; 3、約10.0%或94.1百萬港元將用于營運資金和一般公司用途。
Underwriting Syndicate
Sole Sponsor (1)
中信证券(香港)有限公司 CE AAK249
Overall Coordinators (7)
中信里昂证券有限公司 CE AAB893 中国国际金融香港证券有限公司 CE AEN894 富瑞金融集团香港有限公司 CE ATS546 德意志银行香港分行 招银国际融资有限公司 CE AVM940 浦银国际融资有限公司 CE BFZ375 Guosen Securities (HK) Capital Company Limited CE AUX600
Joint Bookrunners (12)
中信里昂证券有限公司 CE AAB893 中国国际金融香港证券有限公司 CE AEN894 富瑞金融集团香港有限公司 CE ATS546 德意志银行香港分行 招银国际融资有限公司 CE AVM940 浦银国际融资有限公司 CE BFZ375 Guosen Securities (HK) Capital Company Limited CE AUX600 复星国际证券有限公司 CE AAF432 农银国际证券有限公司 CE ACX411 中银国际亚洲有限公司 CE AET863 建银国际金融有限公司 CE AJO225 工银国际证券有限公司 CE ARO299
Joint Lead Managers (15)
中信里昂证券有限公司 CE AAB893 中国国际金融香港证券有限公司 CE AEN894 富瑞金融集团香港有限公司 CE ATS546 德意志银行香港分行 招银国际融资有限公司 CE AVM940 浦银国际融资有限公司 CE BFZ375 Guosen Securities (HK) Capital Company Limited CE AUX600 复星国际证券有限公司 CE AAF432 农银国际证券有限公司 CE ACX411 中银国际亚洲有限公司 CE AET863 建银国际金融有限公司 CE AJO225 工银国际证券有限公司 CE ARO299 富途证券国际(香港)有限公司 CE AZT137 利弗莫尔证券有限公司 CE BJN764 TradeGo Markets Limited CE BRO637
Cornerstone Investors
#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Bradley Lether Pentelute 7,729,920 HKD 0.78% 6 months 2024-12-13
2 FaaS Capital Longevity Limited 19,995,360 HKD 2.02% 6 months 2024-12-13
3 Ginkgo Capital Global Fund SPC-Ginkgo Capital Global Fund I SP 77,320,320 HKD 7.82% 6 months 2024-12-13
4 IntelliMed One Investment Limited 27,260,640 HKD 2.76% 6 months 2024-12-13
5 Mammoth Medical Solutions 61,776,000 HKD 6.24% 6 months 2024-12-13
6 Successful Lotus Limited 39,996,000 HKD 4.04% 6 months 2024-12-13
7 百奥赛图(北京)医药科技股份有限公司 10,649,760 HKD 1.08% 6 months 2024-12-13
8 海棠壹号有限合伙基金 92,785,440 HKD 9.38% 6 months 2024-12-13
Directors & Management
Chairman溫書豪
Company Secretary劉石梅;陳秀玲
No director data available.
Major Shareholders
Major Shareholders & Holdings意像架構投資(香港)有限公司(12.91%);QuantumPharm Roc(8.75%);紅衫中國實體(7.80%);五源資本實體(7.51%);國壽成達(上海)健康產業股權投資中心(有限合伙)(6.91%)
AI AI Analysis
!
The following content is generated by an AI model based on historical IPO data. It does NOT constitute investment advice, solicitation, or recommendation. Past subscription patterns and post-listing performance do not guarantee future results. Data may contain inaccuracies — always verify against official HKEX filings and prospectuses before making any investment decision.

Market Sentiment

The IPO attracted overwhelming demand, reflected in a 103.35x oversubscription ratio. Despite this, the 53.3% hit rate indicates that more than half of applicants received allocations, suggesting a relatively accessible allocation process. The final offer price was set at HK$5.28, but no range data is available to gauge pricing dynamics. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Tier Analysis

The A-tail (800,000 shares applied) and B-head (900,000 shares applied) both expected just 1 lot, revealing a flat allocation curve across the tier boundary. This makes the jump to B-head capital inefficient, as the larger subscription yields no extra shares. Broker fee efficiency likely suffers at B-head due to higher capital costs for the same allocation. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Demographics

Mainland Chinese participants made up 76.9% of the applicant base, signaling strong cross-border interest in this IPO. The gender split was nearly even, with males at 54.7% and females at 45.3%, while the average age of applicants was 44.3 years, pointing to a mature investor demographic. Regional concentration data is not provided, but the high mainland percentage likely reflects Guangdong dominance. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Subscription Tiers
IPO Timeline
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics